Sön 10 dec / År 41 / Nr 5 2023

Good Growth for IRW Consulting

There’s a strong international tendency to outsource clinical trials and the premium full-service CRO IRW Consulting anticipates good growth in all business segments.

IRW Consulting is a premium, full-service, contract research organisation (CRO) that has worked with outsourced clinical research for over 16 years. The company has a strong Nordic presence with regional offices in Denmark, Finland, Norway and Sweden. Their experienced locally-based staff can assist their customers conducting clinical trials as per country specific guidelines.
”We cover all the stages of clinical development, from phase I to phase IV, including paediatric and non-interventional studies and medical device investigations. Our customers range from virtual biotech companies and medtech companies to big pharma and other CROs. Depending on the customer’s requirements, our staff is either outsourced or works with in-house projects,” says Ola Jeppsson, Vice President Nordic, IRW Consulting AB.

More Phase II Studies
There’s a strong international tendency to outsource clinical trials.
”The number of projects are growing in a wide range of therapeutic areas, not least in oncology. For us, it means that we foresee good growth in all business segments and that we’ll probably need to employ more people in 2016-2017; especially since we take on more phase II studies than before,” he adds.
IRW Consulting’s involvement in clinical trials covers both Europe and the US. In Europe, the big countries for clinical trials are Germany, France, the UK and Russia. However, Sweden is about to recapture some of its share of this market that it has lost in recent decades.
”The conditions for performing trials in Sweden are very good and many companies, both from Sweden and abroad, choose to conduct their studies here. With our engagement and extensive network of clinics we can overcome the bottlenecks regarding time and access to patients that sometimes occur,” Ola Jeppsson concludes.